Calumet, Inc. /DE
CLMT Nasdaq Petroleum Refining Financials FY2022–FY2025
Revenue
Total sales reported in the income statement.
$4.1B
1.2%
vs prior year
Operating margin
Operating income as a share of revenue.
2.6%
2.4 pts
Net income
Profit after all expenses, interest and tax.
−$33.8M
Free cash flow
Cash from operations minus capital spending.
$56.6M
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
6.2%
5.8 pts
Market cap
Last close times the latest diluted share count, so it is approximate.
—
P/E
Last close divided by diluted earnings per share over the last four quarters.
—
On −$1.55 EPS (TTM)
What Calumet, Inc. /DE does
No business description yet.
- Legal name
- Calumet, Inc. /DE
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Accession · CIK
- 0002013745-26-000007
0002013745
Revenue and margins
Calumet, Inc. /DE had $4.1B of revenue in fiscal 2025, down 1.2% on the year before.
FY22
Revenue $4.7B
FY23
Revenue $4.2B
FY24
Revenue $4.2B
FY25
Revenue $4.1B
Q3 '23
Revenue $1.1B
Q4 '23
Revenue $977M
Q1 '24
Revenue $1.0B
Q2 '24
Revenue $1.1B
Q3 '24
Revenue $1.1B
Q4 '24
Revenue $950M
Q1 '25
Revenue $994M
Q2 '25
Revenue $1.0B
Q3 '25
Revenue $1.1B
Q4 '25
Revenue $1.0B
Q1 '26
Revenue $1.0B
Q2 '26
Revenue $1.4B
FY22
Gross 7.5%
Operating 2.8%
Net −3.7%
FCF −9.3%
FY23
Gross 10.8%
Operating 6.4%
Net 1.2%
FCF −6.9%
FY24
Gross 5.5%
Operating 0.2%
Net −5.3%
FCF −2.9%
FY25
Gross 5.9%
Operating 2.6%
Net −0.8%
FCF 1.4%
Gross
Operating
Net
FCF
Q3 '23
Gross 22.8%
Operating 18.5%
Net 8.7%
FCF —
Q4 '23
Gross 2.3%
Operating −1.4%
Net −4.9%
FCF −4.0%
Q1 '24
Gross 7.8%
Operating 3.6%
Net −4.1%
FCF −11.3%
Q2 '24
Gross 5.6%
Operating 0.5%
Net −3.4%
FCF 3.7%
Q3 '24
Gross 0.4%
Operating −5.2%
Net −9.1%
FCF −3.2%
Q4 '24
Gross 8.8%
Operating 2.4%
Net −4.3%
FCF −3.0%
Q1 '25
Gross −8.2%
Operating −4.9%
Net −16.3%
FCF −4.7%
Q2 '25
Gross −4.2%
Operating −9.8%
Net −14.4%
FCF −2.0%
Q3 '25
Gross 34.7%
Operating 30.0%
Net 29.1%
FCF 0.0%
Q4 '25
Gross −0.3%
Operating −6.2%
Net −3.6%
FCF 10.0%
Q1 '26
Gross −8.5%
Operating −16.6%
Net −30.8%
FCF −9.7%
Q2 '26
Gross 1.3%
Operating −2.8%
Net −6.6%
FCF 3.7%
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY22
Net income −$173M
FY23
Net income $48.1M
FY24
Net income −$222M
FY25
Net income −$33.8M
Q3 '23
Net income $99.8M
Q4 '23
Net income −$48.0M
Q1 '24
Net income −$41.6M
Q2 '24
Net income −$39.1M
Q3 '24
Net income −$101M
Q4 '24
Net income −$40.7M
Q1 '25
Net income −$162M
Q2 '25
Net income −$148M
Q3 '25
Net income $313M
Q4 '25
Net income −$37.3M
Q1 '26
Net income −$317M
Q2 '26
Net income −$95.9M
FY22
Diluted EPS −$2.14
FY23
Diluted EPS $0.59
FY24
Diluted EPS −$2.67
FY25
Diluted EPS −$0.39
Q3 '23
Diluted EPS $1.24
Q4 '23
Diluted EPS —
Q1 '24
Diluted EPS −$0.51
Q2 '24
Diluted EPS −$0.48
Q3 '24
Diluted EPS −$1.18
Q4 '24
Diluted EPS −$0.50
Q1 '25
Diluted EPS −$1.87
Q2 '25
Diluted EPS −$1.70
Q3 '25
Diluted EPS $3.61
Q4 '25
Diluted EPS −$0.43
Q1 '26
Diluted EPS −$3.64
Q2 '26
Diluted EPS −$1.09
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY22
Return on capital —
Return on equity —
Return on assets —
FY23
Return on capital 18.6%
Return on equity —
Return on assets 1.7%
FY24
Return on capital 0.5%
Return on equity —
Return on assets −8.1%
FY25
Return on capital 6.2%
Return on equity —
Return on assets −1.2%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was $56.6M in fiscal 2025, 1.4% of revenue. Cash from operations minus capital spending.
FY22
Free cash flow −$436M
FY23
Free cash flow −$287M
FY24
Free cash flow −$123M
FY25
Free cash flow $56.6M
Q3 '23
Free cash flow —
Q4 '23
Free cash flow −$39.0M
Q1 '24
Free cash flow −$114M
Q2 '24
Free cash flow $41.8M
Q3 '24
Free cash flow −$34.9M
Q4 '24
Free cash flow −$28.4M
Q1 '25
Free cash flow −$46.9M
Q2 '25
Free cash flow −$20.8M
Q3 '25
Free cash flow $0.0M
Q4 '25
Free cash flow $104M
Q1 '26
Free cash flow −$99.4M
Q2 '26
Free cash flow $54.0M
FY22
Cash from operations $101M
Capital spending $536M
FY23
Cash from operations −$14.9M
Capital spending $272M
FY24
Cash from operations −$46.4M
Capital spending $76.7M
FY25
Cash from operations $109M
Capital spending $52.3M
Cash from operations
Capital spending
Q3 '23
Cash from operations —
Capital spending $48.0M
Q4 '23
Cash from operations −$7.5M
Capital spending $31.5M
Q1 '24
Cash from operations −$94.0M
Capital spending $20.0M
Q2 '24
Cash from operations $66.5M
Capital spending $24.7M
Q3 '24
Cash from operations −$15.5M
Capital spending $19.4M
Q4 '24
Cash from operations −$3.4M
Capital spending $25.0M
Q1 '25
Cash from operations −$29.3M
Capital spending $17.6M
Q2 '25
Cash from operations −$1.8M
Capital spending $19.0M
Q3 '25
Cash from operations $23.5M
Capital spending $23.5M
Q4 '25
Cash from operations $117M
Capital spending $12.7M
Q1 '26
Cash from operations −$86.2M
Capital spending $13.2M
Q2 '26
Cash from operations $92.3M
Capital spending $38.3M
Cash from operations
Capital spending
Dividends, buybacks and share count
Calumet, Inc. /DE returned — to shareholders in fiscal 2025. The diluted share count rose 4.3%.
FY22
Dividends —
Buybacks —
FY23
Dividends —
Buybacks —
FY24
Dividends —
Buybacks —
FY25
Dividends —
Buybacks —
Dividends
Buybacks
FY22
Diluted shares 0.08B
FY23
Diluted shares 0.08B
FY24
Diluted shares 0.08B
FY25
Diluted shares 0.09B
Balance sheet
Cash, debt and the ratios that show how comfortably Calumet, Inc. /DE can carry it.
FY22
Cash $35.2M
Debt —
FY23
Cash $7.9M
Debt $1.9B
FY24
Cash $38.1M
Debt $2.1B
FY25
Cash $125M
Debt $2.2B
Cash
Debt
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $35.2M | $7.9M | $38.1M | $125M |
| Debt incl. finance leases | — | $1.9B | $2.1B | $2.2B |
| Net debt / EBITDA | — | 4.5x | 13.3x | 8.2x |
| Interest coverage | 0.7x | 1.2x | 0.0x | 0.5x |
| Current ratio | — | 0.7x | 0.9x | 1.0x |
| Quick ratio | — | 0.3x | 0.4x | 0.6x |
| Total assets | — | $2.8B | $2.8B | $2.7B |
| Total liabilities | — | $3.0B | $3.2B | $3.2B |
| Shareholders' equity | −$533M | −$490M | −$712M | −$733M |
| Net debt (− = net cash) | — | $1.9B | $2.1B | $2.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✕ | ✓ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✕ | ✕ | ✓ |
| Return on assets rose | — | — | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✕ | ✕ |
| Current ratio rose | — | — | ✓ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✕ |
| Gross margin rose | — | ✓ | ✕ | ✓ |
| Revenue rose relative to assets | — | — | ✕ | ✓ |
| F-score | — / 3 | — / 5 | 2 / 9 | 6 / 9 |
| Accruals ratio | — | 2.3% | −6.4% | −5.2% |
| Altman Z'' | — | −2.63 | −2.26 | −1.84 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $4.7B | $4.2B | $4.2B | $4.1B |
| Gross profit | $352M | $452M | $231M | $246M |
| Operating income | $132M | $267M | $8.1M | $109M |
| Interest expense | $176M | $222M | $237M | $216M |
| Pretax income | −$170M | $49.7M | −$221M | −$126M |
| Income tax | $3.4M | $1.6M | $0.8M | −$92.6M |
| Net income | −$173M | $48.1M | −$222M | −$33.8M |
| Diluted EPS | −$2.14 | $0.59 | −$2.67 | −$0.39 |
| Diluted shares | 0.08B | 0.08B | 0.08B | 0.09B |
| Cash flow | ||||
| Cash from operations | $101M | −$14.9M | −$46.4M | $109M |
| Capital expenditure | $536M | $272M | $76.7M | $52.3M |
| Free cash flow | −$436M | −$287M | −$123M | $56.6M |
| Depreciation and amortization | $98.3M | $147M | $149M | $149M |
| Stock-based compensation | $17.3M | $14.7M | $14.6M | −$4.5M |
| Balance sheet | ||||
| Cash and short-term investments | $35.2M | $7.9M | $38.1M | $125M |
| Total debt | — | $1.9B | $2.1B | $2.2B |
| Finance lease liabilities | — | $3.0M | $2.9M | $1.9M |
| Current assets | — | $795M | $766M | $858M |
| Current liabilities | — | $1.1B | $864M | $841M |
| Inventory | — | $439M | $416M | $385M |
| Property and equipment, net | $1.5B | $1.5B | $1.4B | $1.4B |
| Goodwill | $173M | $173M | $173M | $141M |
| Intangible assets | — | $28.5M | $22.0M | $8.7M |
| Total assets | — | $2.8B | $2.8B | $2.7B |
| Total liabilities | — | $3.0B | $3.2B | $3.2B |
| Shareholders' equity | −$533M | −$490M | −$712M | −$733M |
| Margins | ||||
| Gross margin | 7.5% | 10.8% | 5.5% | 5.9% |
| Operating margin | 2.8% | 6.4% | 0.2% | 2.6% |
| EBITDA margin | 4.9% | 9.9% | 3.7% | 6.2% |
| Net margin | −3.7% | 1.2% | −5.3% | −0.8% |
| FCF margin | −9.3% | −6.9% | −2.9% | 1.4% |
| Returns | ||||
| Return on capital | — | 18.6% | 0.5% | 6.2% |
| Return on capital employed | — | 16.3% | 0.4% | 5.9% |
| Return on assets | — | 1.7% | −8.1% | −1.2% |
| Growth | ||||
| Revenue growth | — | −10.8% | 0.2% | −1.2% |
| Net income growth | — | — | −561.5% | — |
| EPS growth | — | — | −552.5% | — |
| Share count change | — | 0.9% | 3.8% | 4.3% |
| Financial health | ||||
| Net debt / EBITDA | — | 4.5x | 13.3x | 8.2x |
| Interest coverage | 0.7x | 1.2x | 0.0x | 0.5x |
| Current ratio | — | 0.7x | 0.9x | 1.0x |
| Quick ratio | — | 0.3x | 0.4x | 0.6x |
| Capital allocation | ||||
| Capex / revenue | 11.4% | 6.5% | 1.8% | 1.3% |
| Stock comp / revenue | 0.4% | 0.4% | 0.3% | −0.1% |
| Quality scores | ||||
| Piotroski F-score | — | — | 2.0 | 6.0 |
| Altman Z'' | — | −2.6 | −2.3 | −1.8 |
| Accruals ratio | — | 2.3% | −6.4% | −5.2% |
Source: SEC EDGAR XBRL filings (CIK 0002013745). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.